Results
1 -
10 of
18Genistein alters caffeine exposure in healthy female volunteers, European Journal of Clinical Pharmacology Determination of urine caffeine and its metabolites by use of high-performance liquid chromatography-tandem mass spectrometry: estimating dietary caffeine exposure and metabolic phenotyping in population studies, Analytical and Bioanalytical Chemistry Pharmacogenomics in and its Influence on Pharmacokinetics, Drug Discovery and Evaluation: Methods in Clinical Pharmacology Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure, European Journal of Clinical Pharmacology Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?, European Journal of Clinical Pharmacology Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities, European Journal of Clinical Pharmacology Disposition Kinetics of Caffeine and Paraxanthine in Nile Tilapia (Oreochromis niloticus): Characterization of the Main Metabolites, Archives of Environmental Contamination and Toxicology Re-investigation of the concordance of human NAT2 phenotypes and genotypes, Archives of Toxicology Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions, European Journal of Clinical Pharmacology